13F HOLDINGS REPORT (Amended)
Altium Capital Management LP
Quarter ended Q1 2025 · Filed May 13, 2025 · Accession 0001420506-25-000988
Total Value
$41.5M
Positions
24
Other Managers
0
Confidential Omitted
No
Holdings (24)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ZEVRA THERAPEUTICS INC | ZVRA | 1,287,333 | $9.6M | 23.23% |
| 2 | ALNYLAM PHARMACEUTICALS INC | ALNY | 25,000 | $6.8M | 16.27% |
| 3 | EVOLUS INC | EOLS | 296,193 | $3.6M | 8.59% |
| 4 | XTANT MED HLDGS INC | 98420P308 | 7,252,998 | $3.4M | 8.21% |
| 5 | AVADEL PHARMACEUTICALS PLC | G29687103 | 419,131 | $3.3M | 7.91% |
| 6 | CONTINEUM THERAPEUTICS INC | CTNM | 303,857 | $2.1M | 5.11% |
| 7 | PROFOUND MED CORP | PROF | 360,589 | $2.1M | 5.06% |
| 8 | XENON PHARMACEUTICALS INC | XENE | 60,251 | $2.0M | 4.87% |
| 9 | ESSA PHARMA INC | 29668H708 | 1,050,369 | $1.7M | 4.00% |
| 10 | SKYE BIOSCIENCE INC | SKYE | 904,865 | $1.4M | 3.47% |
| 11 | ALPHA COGNITION INC | ACOG | 177,416 | $897,725 | 2.16% |
| 12 | REZOLUTE INC | RZLT | 303,949 | $881,452 | 2.12% |
| 13 | NEKTAR THERAPEUTICS | NKTR | 1,051,379 | $714,938 | 1.72% |
| 14 | ANTERIS TECHNOLOGIES GLOBAL | AVR | 168,589 | $613,664 | 1.48% |
| 15 | LARIMAR THERAPEUTICS INC | LRMR | 273,204 | $587,389 | 1.42% |
| 16 | PROMIS NEUROSCIENCES INC | PMN | 574,248 | $399,389 | 0.96% |
| 17 | ENVVENO MEDICAL CORPORATION | NVNO | 123,256 | $324,163 | 0.78% |
| 18 | XENON PHARMACEUTICALS INC | XENE | 9,400 | $315,370 | 0.76% |
| 19 | INTELLIGENT BIO SOLUTIONS IN | 36151G600 | 149,252 | $214,923 | 0.52% |
| 20 | KARYOPHARM THERAPEUTICS INC | KPTI | 49,333 | $184,505 | 0.44% |
| 21 | SHARPS TECHNOLOGY INC | STSSW | 4,044,149 | $110,405 | 0.27% |
| 22 | LOGICMARK INC | LGMK | 5,395,308 | $106,827 | 0.26% |
| 23 | SUNSHINE BIOPHARMA INC | SBFMW | 50,466 | $96,390 | 0.23% |
| 24 | BETTER CHOICE CO INC | SRXH | 38,984 | $67,052 | 0.16% |